1101 Hamlin Road
13 articles with KBI BioPharma
CYTOSEN THERAPEUTICS AND KBI BIOPHARMA ENTER INTO STRATEGIC PARTNERSHIP TO MANUFACTURE NK CELLS AND NANOPARTICLES
CytoSen Therapeutics and KBI Biopharma today announced a strategic partnership to manufacture therapeutic Natural Killer (NK) cells using a proprietary and scalable, closed system manufacturing process.
KBI Biopharma BVBA initiated its first client-sponsored programs in May 2018.
ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development
Collaboration will provide clients competitive advantages, improve speed to market
KBI Biopharma Acquires Elion Labs to Further Expand Industry-Leading Biophysical and Analytical Characterization Capabilities
KBI BioPharma (KBI) has completed the acquisition of the assets of Elion Labs (Elion), a leading contract services organization in Louisville, CO founded to serve the analytical development and product characterization needs of the biopharmaceutical industry.
KBI BioPharma Acquires Alliance Protein Laboratories, Expands Biophysical Characterization Capabilities
JSR Life Sciences Agrees To Acquire Pioneering Cell Line Developer Selexis SA And Integrate Selexis With KBI BioPharma
KBI BioPharma Selects The Windshire Group's And Simplyfeye's Processpad Continued Process Verification Solution